Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Pharmaceutical Continuous Manufacturing Market Value Growth And Long-Term Outlook
The market size for pharmaceutical continuous manufacturing has experienced rapid expansion in recent years. This market is projected to expand from $2.69 billion in 2025 to $2.97 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.4%. Historically, this growth can be attributed to several factors, including escalating drug demand volumes, the imperative for enhanced production efficiency, significant variability in batch manufacturing, mounting cost pressures on pharmaceutical enterprises, and initial regulatory pilot approvals.
The pharmaceutical continuous manufacturing market size is expected to experience significant expansion in the coming years. It is forecast to grow to $4.58 billion in 2030, at a compound annual growth rate (CAGR) of 11.4%. This projected growth over the forecast period can be attributed to several factors, including the increasing adoption of pcm by major pharmaceutical firms, rising investment in smart factories, the demand for accelerated scale-up and commercialization, a strong focus on supply chain resilience, and advancements in continuous processing equipment. Prominent trends for the forecast period include a shift from traditional batch production to end-to-end continuous manufacturing, greater adoption of modular and flexible production lines, an intensified focus on real-time quality assurance and control, the expansion of continuous manufacturing for active pharmaceutical ingredient (API) production, and growing regulatory support for continuous manufacturing practices.
Get A Free Sample Report With In-Depth Market Insights:
Pharmaceutical Continuous Manufacturing Market Growth Factors Behind Sustained Expansion
The growing implementation of industrial automation is anticipated to stimulate the expansion of the pharmaceutical continuous manufacturing market moving forward. Industrial automation pertains to the utilization of control systems, such as computers or robots, to manage diverse processes and machinery within an industry, thereby substituting or augmenting human intervention. This automation assists pharmaceutical continuous manufacturing by providing monitoring and real-time feedback control in CM processes, which helps minimize human error and ensures consistent product quality. For instance, in September 2023, the World Robotics report, published by the International Federation of Robotics, a Germany-based professional non-profit organization, reported 553,052 industrial robot installations in factories worldwide, reflecting a 5% year-on-year growth rate in 2022. Hence, the increasing deployment of industrial automation is driving the growth of the pharmaceutical continuous manufacturing market.
Pharmaceutical Continuous Manufacturing Market Segment Outlook: Which Categories Are Growing Fastest?
The pharmaceutical continuous manufacturing market covered in this report is segmented –
1) By Product: Integrated Continuous System, Control And Software, Semi-Continuous System
2) By Therapeutics Type: Large Molecule, Small Molecule
3) By Formulation: Solid Formation, Liquid And Semi-Solid Formation
4) By Application: Final Drug Product Manufacturing, Active Pharmaceutical Ingredient (API) Manufacturing
5) By End-Users: Pharmaceutical Companies, Contract Manufacturing Organization, Other End-Users
Subsegments:
1) By Integrated Continuous System: Continuous Mixer Systems, Continuous Granulation Systems, Continuous Tablet Press Systems, Continuous Coating Systems
2) By Control and Software: Process Analytical Technology (PAT) Tools, Manufacturing Execution Systems (MES), Control Software for Automation, Data Management and Visualization Software
3) By Semi-Continuous System: Batch-to-Continuous Transition Systems, Hybrid Systems, Semi-Continuous Granulation and Drying Systems
Pharmaceutical Continuous Manufacturing Market Industry Trends Fueling Future Revenue Growth
Major companies engaged in the pharmaceutical continuous manufacturing market are concentrating on developing advanced equipment, such as continuous manufacturing lines, to secure a competitive advantage in the sector. A Continuous Manufacturing (CM) line is a specialized production setup where raw materials are smoothly converted into final products without any interruptions or delays. For instance, in January 2023, WuXi STA, a China-based contract research, development, and manufacturing organization (CRDMO), launched its Continuous Manufacturing (CM) line for oral solids in Wuxi City, China. This CM line, compliant with global cGMP regulations, introduces enhancements in oral drug development by incorporating continuous direct compression equipment for dispensing, blending, lubrication, tablet compression, and coating. Notably, Process Analytical Technology (PAT) is integrated to monitor blending uniformity in real-time, ensuring high product quality.
Pharmaceutical Continuous Manufacturing Market Leading Companies And Competitive Benchmarking
Major companies operating in the pharmaceutical continuous manufacturing market are Pfizer Inc., Robert Bosch GmbH, Siemens AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline Plc., Eli Lilly and Company, Corning Inc., Vertex Pharmaceuticals, Lonza Group Ltd., GEA Group AG, Catalent Inc., Mettler Toledo, Patheon, Cytiva, Samsung Biologics Co.Ltd., WuXi Biologics, Syntegon Technology GmbH, Coperion GmbH, Hosokawa Micron Group, FUJIFILM Diosynth Biotechnologies, Leistritz AG, Glatt GmbH, Freund-Vector Corp., SK biotek Co. Ltd., Gericke AG, GEBRÜDER LÖDIGE MASCHINENBAU GmbH, Munson Machinery Company Inc., L.B. Bohle Maschinen und Verfahren GmbH, KORSCH AG, Chemtrix BV
View The Full Pharmaceutical Continuous Manufacturing Market Report:
Pharmaceutical Continuous Manufacturing Market Top Region: Where Does Most Revenue Come From?
Western Europe was the largest region in the pharmaceutical continuous manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical continuous manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
